N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide

C18H18N6O2 — CID 92568978

IUPACN-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide
SMILESO=C(NCc1nnc(-c2cnccn2)o1)c1cccc(N2CCCC2)c1
InChIInChI=1S/C18H18N6O2/c25-17(13-4-3-5-14(10-13)24-8-1-2-9-24)21-12-16-22-23-18(26-16)15-11-19-6-7-20-15/h3-7,10-11H,1-2,8-9,12H2,(H,21,25)
InChIKeyBCDYPQLHQMOWBC-UHFFFAOYSA-N
MW350.38 g/mol
LogP2.06
Rot. Bonds5

About N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide

N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide (PubChem CID 92568978) has the molecular formula C18H18N6O2 and a molecular weight of 350.38 g/mol. Its IUPAC name is N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide.

Molecular Properties

Compound NameN-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide
PubChem CID92568978
Molecular FormulaC18H18N6O2
Molecular Weight350.38 g/mol
Exact Mass350.15
IUPAC NameN-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide
SMILESO=C(NCc1nnc(-c2cnccn2)o1)c1cccc(N2CCCC2)c1
InChIInChI=1S/C18H18N6O2/c25-17(13-4-3-5-14(10-13)24-8-1-2-9-24)21-12-16-22-23-18(26-16)15-11-19-6-7-20-15/h3-7,10-11H,1-2,8-9,12H2,(H,21,25)
InChIKeyBCDYPQLHQMOWBC-UHFFFAOYSA-N
XLogP2.06
TPSA97.04 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500350.38
LogP ≤ 52.06
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide?
The IUPAC name of N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide (CID 92568978) is N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide.
What is the SMILES notation for N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide?
The canonical SMILES for N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide is O=C(NCc1nnc(-c2cnccn2)o1)c1cccc(N2CCCC2)c1.
What is the InChIKey of N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide?
The InChIKey is BCDYPQLHQMOWBC-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18N6O2/c25-17(13-4-3-5-14(10-13)24-8-1-2-9-24)21-12-16-22-23-18(26-16)15-11-19-6-7-20-15/h3-7,10-11H,1-2,8-9,12H2,(H,21,25).
What are the key properties of N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide?
N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide has a molecular weight of 350.38 g/mol, XLogP of 2.06, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)methyl]-3-pyrrolidin-1-ylbenzamide is sourced from PubChem (CID 92568978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).